DOT World

DOT World

Tokyo, Japan· Est.

A Japanese CRO providing flexible, rapid clinical trial support for investigator-initiated studies, corporate drug development, and SaMD/medical device programs.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

A Japanese CRO providing flexible, rapid clinical trial support for investigator-initiated studies, corporate drug development, and SaMD/medical device programs.

Broad Life SciencesRare DiseasesDigital Health

Technology Platform

Clinical trial service platform with specialized expertise in investigator-initiated trials and Software as a Medical Device (SaMD) development support, leveraging operational knowledge from 200+ trials.

Opportunities

Growth in Japan's digital health/SaMD sector and increased outsourcing of investigator-initiated trials provide expansion opportunities, particularly as regulatory pathways for software-based medical devices mature.

Risk Factors

High dependency on Japan's domestic clinical research market, competition from larger global CROs, and sensitivity to fluctuations in pharmaceutical and medical device R&D spending.

Competitive Landscape

Competes with other Japanese CROs and global players like IQVIA and Parexel, differentiating through specialized focus on investigator-initiated trials, rare diseases, and SaMD development support for smaller clients.